ATI RN
ATI RN Pharmacology 2023 II Questions
Extract:
Question 1 of 5
A nurse is caring for a client who is experiencing manifestations of acute cocaine toxicity. Which of the following medication prescriptions should the nurse anticipate administering?
Correct Answer: C
Rationale: The correct answer is C: Diazepam. Diazepam is a benzodiazepine that can help manage the agitation, anxiety, and seizures associated with acute cocaine toxicity by acting as a sedative and anticonvulsant. Aspirin (
A) is not indicated for this condition. Sodium bicarbonate (
B) is used for tricyclic antidepressant overdose, not cocaine toxicity. Naloxone (
D) is used for opioid overdose, not cocaine toxicity.
Question 2 of 5
A nurse is providing teaching to a client who has a new prescription for rifampin. Which of the following statements should the nurse include in the teaching?
Correct Answer: D
Rationale: The correct answer is D: Your urine will turn orange while you are taking this medication. Rifampin is known to cause orange discoloration of bodily fluids, including urine. This is a harmless side effect but important for the client to be aware of.
Choice A is incorrect as rifampin should be taken on an empty stomach, not at bedtime.
Choice B is incorrect because wearing soft contact lenses is not recommended due to the risk of discoloration.
Choice C is incorrect as rifampin can reduce the effectiveness of oral contraceptives, so an alternative form of birth control should be used.
Question 3 of 5
A nurse is planning to administer a prefilled syringe of enoxaparin to a client. Which of the following actions should the nurse take?
Correct Answer: B
Rationale: The correct answer is B: Administer the medication into the anterolateral or posterolateral abdominal area. Enoxaparin is a low molecular weight heparin that should be injected subcutaneously into the fatty tissue in the abdomen. This area has a good blood supply, allowing for better absorption of the medication. The nurse should choose an area away from the umbilicus and any scar tissue to prevent discomfort and ensure proper absorption. Massaging the injection site after administering the medication (
Choice
A) is not recommended as it can cause bruising and discomfort. Holding the skin taut at the injection site (
Choice
C) is unnecessary and may increase the risk of injecting the medication too deeply. Expelling the air bubble from the syringe (
Choice
D) is not necessary for subcutaneous injections and may lead to medication wastage.
Question 4 of 5
A nurse is administering 4 mg of hydromorphone to a client by mouth every 4 hr. The medication is provided as hydromorphone 8 mg per tablet. Which of the following actions is appropriate for the nurse to take?
Correct Answer: B
Rationale: The correct answer is B: Dispose of the remaining medication while another nurse observes. This is appropriate to ensure proper disposal of the unused portion of the medication to prevent diversion or misuse. By disposing of the remaining medication with another nurse observing, it ensures accountability and adherence to medication safety protocols.
Choice A is incorrect because returning the medication to the facility's pharmacy can lead to confusion and potentially unsafe practices.
Choice C is incorrect as storing the remaining half of the pill in the automated medication dispensing system can lead to errors in medication administration.
Choice D is incorrect as placing the remaining half of the pill in the unit-dose package can also result in medication errors. It is essential to follow proper disposal procedures to maintain patient safety and prevent medication errors.
Question 5 of 5
A nurse is planning care for a group of clients. Which of the following client's medications should be monitored by the nurse for hearing loss related to a medication interaction?
Correct Answer: B
Rationale: The correct answer is B: Furosemide and amikacin. Furosemide is a loop diuretic known to cause ototoxicity (hearing loss) and when combined with amikacin, an aminoglycoside antibiotic also known to cause ototoxicity, the risk of hearing loss is increased. Digoxin (
A) is associated with visual disturbances, not hearing loss. Losartan and atorvastatin (
C) are not known to cause hearing loss. Propranolol and raloxifene (
D) do not have ototoxic effects.